Fortress Biotech CEO to speak at H.C. Wainwright Royalty Company Virtual Conference on May 6, 2026

Fortress Biotech, a biopharmaceutical company focused on advancing assets for shareholder value, announced that CEO Lindsay A. Rosenwald will participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. The event highlights Fortress's ongoing efforts to expand its portfolio in oncology, dermatology, and rare diseases through partnerships with leading research institutions and companies. This participation underscores Fortress's strategy to enhance long-term value via product revenue, equity holdings, and royalty income.